These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


384 related items for PubMed ID: 30640536

  • 21. Assessing the infiltration of immune cells in the upper trachea mucosa after infectious laryngotracheitis virus (ILTV) vaccination and challenge.
    Maekawa D, Whang P, Riblet SM, Hurley DJ, Guy JS, García M.
    Avian Pathol; 2021 Dec; 50(6):540-556. PubMed ID: 34612113
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.
    Han MG, Kim SJ.
    Avian Dis; 2003 Dec; 47(2):261-71. PubMed ID: 12887186
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of the transcriptional status of host cytokines and viral genes in the trachea of vaccinated and non-vaccinated chickens after challenge with the infectious laryngotracheitis virus.
    Vagnozzi A, Riblet S, Zavala G, Ecco R, Afonso CL, García M.
    Avian Pathol; 2016 Dec; 45(1):106-13. PubMed ID: 26926298
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Attenuation and protection efficacy of ORF C gene-deleted recombinant of infectious laryngotracheitis virus.
    Garcia M, Spatz SJ, Cheng Y, Riblet SM, Volkening JD, Schneiders GH.
    J Gen Virol; 2016 Sep; 97(9):2352-2362. PubMed ID: 27283114
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cross-protective immune responses between genotypically distinct lineages of infectious laryngotracheitis viruses.
    Lee SW, Markham PF, Coppo MJ, Legione AR, Shil NK, Quinteros JA, Noormohammadi AH, Browning GF, Hartley CA, Devlin JM.
    Avian Dis; 2014 Mar; 58(1):147-52. PubMed ID: 24758128
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M, Kumar S, Khattar SK, Gebreluul GT, Paldurai A, Samal SK.
    Vaccine; 2014 Jun 12; 32(28):3555-63. PubMed ID: 24793943
    [Abstract] [Full Text] [Related]

  • 39. Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.
    Perez-Contreras A, Barboza-Solis C, Najimudeen SM, Checkley S, Meer FV, Joseph T, King R, Ravi M, Peters D, Fonseca K, Gagnon CA, Ojkic D, Abdul-Careem MF.
    Viruses; 2021 Mar 24; 13(4):. PubMed ID: 33805117
    [Abstract] [Full Text] [Related]

  • 40. A Cell Line Adapted Infectious Laryngotracheitis Virus Strain (BΔORFC) for in ovo and Hatchery Spray Vaccination Alone or in Combination with a Recombinant HVT-LT Vaccine.
    Maekawa D, Riblet SM, Whang P, Alvarado I, García M.
    Avian Dis; 2021 Sep 24; 65(3):500-507. PubMed ID: 34699149
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 20.